HomeROVI • VIE
add
Laboratorios Farmaceuticos ROVI SA
Previous close
€52.30
Day range
€52.60 - €52.85
Year range
€45.82 - €90.75
Market cap
2.69B EUR
Avg Volume
16.00
P/E ratio
19.23
Dividend yield
1.78%
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 154.89M | 2.46% |
Operating expense | 67.53M | 1.46% |
Net income | 18.10M | 20.99% |
Net profit margin | 11.69 | 18.08% |
Earnings per share | — | — |
EBITDA | 30.14M | 17.13% |
Effective tax rate | 20.89% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 29.31M | 123.97% |
Total assets | 813.96M | 4.53% |
Total liabilities | 214.50M | -15.85% |
Total equity | 599.47M | — |
Shares outstanding | 51.15M | — |
Price to book | 4.54 | — |
Return on assets | 6.95% | — |
Return on capital | 8.14% | — |
Cash Flow
Net change in cash
| (EUR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 18.10M | 20.99% |
Cash from operations | 18.84M | 21.23% |
Cash from investing | -11.59M | -26.66% |
Cash from financing | -6.99M | 62.45% |
Net change in cash | 2.12M | 117.32% |
Free cash flow | 6.14M | 81.30% |
About
Founded
1946
Website
Employees
2,197
